Johnson & Johnson
- Consumer Products
- Latest 86.82
- Currency US$
- Change -0.39
- Percent Change -0.447 %
- Volume 10,390,046
- Fri May 24, 2013 4:01 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Apr 16||$1.41||Jul 16||$1.40|
12 months ended May 25, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Head OfficeONE JOHNSON & JOHNSON PLZ